Market Analysis: Global Vitiligo Treatment Market

Vitiligo treatment market is expected to grow at a healthy CAGR in the forecast period of 2019-2026. Growing incidence ocular surface injuries as it can contribute to the neurotrophic keratitis and development of advanced therapies and treatment are the key factors for market growth

Market Definition: Global Vitiligo Treatment Market

Vitiligo is lifelong dermatology disorders characterized by depigmentation of the skin cause by the death or malfunctioning of the skin's pigment-making cells called melanocytes. As a result well-defined white patches appear on the skin. It tends to continue over time, causing larger areas of skin to lose pigment. It does not affect the physical health however, can limit social activities and have a negative impact on the quality of life.

According to the statistics published by U.S. Department of Health & Human Services, it is estimated about 0.5 to 1% of the population worldwide is suffering from vitiligo. High demand of novel treatment and huge investment on research and development are drivers for market growth.

Get More Insights About Global Vitiligo Treatment Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Market Drivers

• Growing prevalence of urticaria worldwide is drive the market
• Huge financial support to the researchers for developing novel intervention is boosting the market growth
• High demand of disease specific novel treatment can also act as a market driver
• Advancement in treatment and incorporation of novel formulation can improve the ease the pain of cold sores is also act as factors that drive the market

Market Restraints

• Patent expiry of branded drugs and introduction of generics is also acting as a challenging factor for the growth of this market
• Low healthcare budget in some developing countries is hamper the market growth

Know more about this report https://www.databridgemarketresearch.com/reports/global-vitiligo-treatment-market

Segmentation: Global Vitiligo Treatment Market

By Type

• Nonsegmental Vitiligo
• Segmental Vitiligo

By Therapy

• Light Therapy
• Repigmentation Therapy

By Treatment Type

• Medication
• Pharmacological
• Non-pharmacological
• Surgery
• Skin grafting
• Blister grafting

By Drugs

• Calcineurin Inhibitors
• Pimecrolimus
• Tacrolimus
• Melanocyte-Stimulating Hormone
• Afamelanotide
• Others

By Route of Administration

• Oral
• Topical
• Others

 By End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Geography

• North America
  • U.S.
  • Canada
  • Mexico
• South America
  • Brazil
  • Rest of South America
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
• Middle East & Africa
  • South Africa
  • Rest of Middle East & Africa

Key Developments in the Market:

• In September 2019, Aclaris Therapeutics, Inc is developing novel drug ATI-502, JAK1/JAK3 Inhibitor for the treatment of alopecia areata, vitiligo and atomic dermatitis. If trial successful, it will improve the treatment landscape for miilion of patients suffering from vitiligo.
• In January 2017, Clarify Medical, Inc received an approval from the FDA for the Clarify Medical Phototherapy System, a home-based light therapy device for the treatment of chronic skin diseases such as psoriasis, vitiligo and eczema. The approval of this devices provides a novel treatment option and major advances that offer complete heal of this condition.

Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/gl...

Competitive Analysis:

Global Vitiligo treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Vitiligo treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the Global Vitiligo treatment market are CLINUVEL PHARMACEUTICALS LTD, Clarify Medical, Inc, Incyte Corporation, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd, Bausch Health, Novartis AG, Mylan N.V., Pfizer Inc, Strides Pharma Science Limited, Panacea Biotec Ltd, Belcher Pharmaceuticals, LCC, LEO Pharma A/S, Astellas Pharma Inc, and others.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-vitiligo-treatment-market

Browse Trending Related Reports @

·        Rosacea Treatment Market

·        Smith-Lemli-Opitz Syndrome Market

·        Urothelial Cancer Drugs Market

·        Pyelonephritis Treatment Market

·        Dry Eye Syndrome Market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]